Newborn affected by maternal use of cannabis

This code identifies a newborn whose health status is influenced by the mother's use of cannabis during pregnancy. It indicates that the infant has been exposed to cannabis prenatally, which may lead to various developmental, neurological, or behavioral effects. This diagnosis does not necessarily imply active withdrawal symptoms but rather the impact of maternal substance use.

Assign this code when documentation explicitly states maternal cannabis use during pregnancy and its potential or confirmed effect on the newborn. This is typically used when the newborn is being evaluated for potential complications or monitoring related to this exposure. Supporting documentation includes maternal history, toxicology screens (maternal or neonatal), and clinical assessment of the infant.

• Always sequence this code as a secondary diagnosis, following the code for the specific condition or symptom the newborn is experiencing due to the exposure.
• Do not use this code if the maternal cannabis use is documented but there is no indication of an effect on the newborn.
• Consider additional codes for specific manifestations in the newborn, such as neonatal withdrawal symptoms (P96.1) if present, or other developmental issues.